An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination- these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The classification of Veterinary Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2017 is about 41.5%. The Subcutaneous in 2016 is about 23.4%.
Veterinary Vaccine Adjuvants is widely sales for Livestock Vaccines, Companion Animals Vaccines. The most proportion of Veterinary Vaccine Adjuvants is used for Livestock Vaccines, and the consumption proportion is about 88.4% in 2017.
Europe is the largest consumption place, with a consumption market share nearly 43.3% in 2017. Following Europe, North America is the second largest consumption place with the consumption market share of 26%; China is also an important sales region for the Veterinary Vaccine Adjuvants.
Market competition is intense. SEPPIC, SDA BIO, Brenntag Biosector, SPI Pharma, etc. are the leaders of the industry. They hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.
According to this study, over the next five years the Veterinary Vaccine market will register a 26.2% CAGR in terms of revenue, the global market size will reach USD 1050 million by 2024, from USD 260 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Veterinary Vaccine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Vaccine market by product type, application, key manufacturers and key regions and countries.
This study considers the Veterinary Vaccine value and volume generated from the sales of the following segments-
Segmentation by product type- breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Oral
Subcutaneous
Intramuscular
Others
Segmentation by application- breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Livestock Vaccines
Companion Animals Vaccines
This report also splits the market by region- Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report- Breakdown data in in Chapter 3.
SEPPIC
SDA BIO
Brenntag Biosector
SPI Pharma
MVP Laboratories
Zhuoyue
Zhiju Bio
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Veterinary Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Veterinary Vaccine market by identifying its various subsegments.
Focuses on the key global Veterinary Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Veterinary Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Veterinary Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
